These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23929798)

  • 21. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring and predicting surgeons' practice styles for breast cancer treatment in older women.
    Mandelblatt JS; Berg CD; Meropol NJ; Edge SB; Gold K; Hwang YT; Hadley J
    Med Care; 2001 Mar; 39(3):228-42. PubMed ID: 11242318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines.
    Stark R; Kirchberger I; Hunger M; Heier M; Leidl R; von Scheidt W; Meisinger C; Holle R
    Clin Res Cardiol; 2014 Mar; 103(3):237-45. PubMed ID: 24287605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Country differences in the diagnosis and management of coronary heart disease - a comparison between the US, the UK and Germany.
    von dem Knesebeck O; Bönte M; Siegrist J; Marceau L; Link C; Arber S; Adams A; McKinlay J
    BMC Health Serv Res; 2008 Sep; 8():198. PubMed ID: 18823556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
    Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gender differences in baseline characteristics and statin intervention among outpatients with coronary heart disease in China: the China Cholesterol Education Program.
    Li X; Xu Y; Li J; Hu D
    Clin Cardiol; 2009 Jun; 32(6):308-14. PubMed ID: 19569062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.
    Frolkis JP; Zyzanski SJ; Schwartz JM; Suhan PS
    Circulation; 1998 Sep; 98(9):851-5. PubMed ID: 9738639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do physicians attend to base rates? Prevalence data and statistical discrimination in the diagnosis of coronary heart disease.
    Maserejian NN; Lutfey KE; McKinlay JB
    Health Serv Res; 2009 Dec; 44(6):1933-49. PubMed ID: 19780850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guideline-based COPD management in a resource-limited setting - physicians' understanding, adherence and barriers: a cross-sectional survey of internal and family medicine hospital-based physicians in Nigeria.
    Desalu OO; Onyedum CC; Adeoti AO; Gundiri LB; Fadare JO; Adekeye KA; Onyeri KD; Fawibe AE
    Prim Care Respir J; 2013 Mar; 22(1):79-85. PubMed ID: 23443222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.
    Ferrieres J; De Ferrari GM; Hermans MP; Elisaf M; Toth PP; Horack M; Brudi P; Lautsch D; Bash LD; Baxter CA; Ashton V; Ambegaonkar B; Gitt AK
    Eur J Prev Cardiol; 2018 Dec; 25(18):1966-1976. PubMed ID: 30335504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.
    Yabroff KR; Saraiya M; Meissner HI; Haggstrom DA; Wideroff L; Yuan G; Berkowitz Z; Davis WW; Benard VB; Coughlin SS
    Ann Intern Med; 2009 Nov; 151(9):602-11. PubMed ID: 19884621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to guidelines for the prescribing of double and triple combinations of antithrombotic agents.
    Warlé-Van Herwaarden MF; Roukens M; Pop GA; Lamfers EJ; De Smet PA; Kramers C
    Eur J Prev Cardiol; 2014 Feb; 21(2):231-43. PubMed ID: 22684153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Swapping horses midstream: factors related to physicians' changing their minds about a diagnosis.
    Eva KW; Link CL; Lutfey KE; McKinlay JB
    Acad Med; 2010 Jul; 85(7):1112-7. PubMed ID: 20592506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cascades of Care After Incidental Findings in a US National Survey of Physicians.
    Ganguli I; Simpkin AL; Lupo C; Weissman A; Mainor AJ; Orav EJ; Rosenthal MB; Colla CH; Sequist TD
    JAMA Netw Open; 2019 Oct; 2(10):e1913325. PubMed ID: 31617925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial.
    Herrmann-Lingen C; Albus C; de Zwaan M; Geiser F; Heinemann K; Hellmich M; Michal M; Sadlonova M; Tostmann R; Wachter R; Herbeck Belnap B
    BMC Cardiovasc Disord; 2020 Dec; 20(1):520. PubMed ID: 33302871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
    Kones R
    Vasc Health Risk Manag; 2013; 9():617-70. PubMed ID: 24174878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid targets in clinical practice: successes, failures and lessons to be learned.
    Dunne M; Mac Ananey O; Markham C; Maher V
    Ir J Med Sci; 2013 Dec; 182(4):673-8. PubMed ID: 23616070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay.
    Tsai M; Lo S; Audeh W; Qamar R; Budway R; Levine E; Whitworth P; Mavromatis B; Zon R; Oldham D; Untch S; Treece T; Blumencranz L; Soliman H
    JAMA Oncol; 2018 Jan; 4(1):e173470. PubMed ID: 29075751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.